evidence of CMV causing a vasculopathy is derived from the evidence of association of CMV and advanced progression of atherosclerosis and vasculopathy in heart-transplant recipients. 16 
Helicobacter pylori
Helicobacter pylori is a bacterium responsible for inflammation of the stomach lining, ulceration, and stomach cancer. H. pylori has been found at higher rates in carotid endarterectomy plaque samples compared with normal control samples derived from autopsy samples in some 17 but not all studies. Furthermore, specific strains of H. pylori, such as those expressing cytotoxin gene A (CagA-positive), are believed to specifically contribute to the atherosclerotic process.
18

Mechanisms of Pathogen-mediated Effects on Atherosclerosis
Direct infection of cells lining arterial walls can lead to changes in transcription profiles and regulatory pathways that can result in endothelial dysfunction, smooth-muscle proliferation, or increased cytokine secretion. 19 HSV1 infection of human arterial smooth-muscle tissue causes decreased translation of cholesterol ester hydrolase messenger RNA (mRNA) 20 and infection has been documented to interfere with the ability of cells to transport and metabolize cholesterol. 21, 22 CMV has been shown to induce vascular injury 23 and double the rate of smooth-muscle-cell proliferation 24 in rat models undergoing aortic allografts. In in vitro studies of human arterial smooth-muscle tissue, CMV has been shown to replicate for prolonged periods compared with shorter observed survival in human lung fibroblasts. 25 Pathogens may also exert non-specific effects on vessel walls, far removed from any localized infections. For example, research indicates that exposure early in life may be sufficient to pre-condition coronary arteries to atherosclerosis. A Swedish study of 175 autopsied children reported increased intima thickening in children with viral (32%) and bacterial (21%) infections compared with groups with no evidence of infection (16%). 26 A case-control study from the same group found increased intima-media thickness (IMT) in cases (0.48±0.02mm) compared with controls (0.41±0.02mm), while no difference between groups was observed during the acute phase of infection. 27 One implication of this research is that atherosclerosis may be a delayed sequela of an acute infection. Other studies of non-specific effects of chronic infection have focused on elevated levels of serum cytokines that may affect atheromatous plaque progression by influencing macrophage activity. In vitro studies have shown C. pneumoniae to induce cytokine secretion in infected mononuclear cells that can directly affect atheroma progression 28 and induce macrophage conversion to foam cells, a critical aspect of atherosclerotic plaque progression. 29 Pathogen infection can also increase the risk for pro-thrombotic events by altering platelet activation and dynamics with leukocytes.
The P-selectin adhesion molecule is the most critical determinant of platelet activation. In vitro analysis of human platelets incubated with C. pneumoniae found an increased expression of P-selectin using flow cytometry and the initiation of widespread aggregation as measured by lumiaggregometry. 30 Platelet activation and platelet-leukocyte aggregates were shown to be significantly elevated in recent stroke cases compared with controls of healthy employees. These results were adjusted for risk factors and a dose-response was observed. A second cohort study by the same group among 572 subjects found advanced atherosclerosis, as measured by angiography, Doppler, and ankle-arm indices, to be significantly higher in those individuals with six to eight serologies. 50 Only 6% of this population was observed to have six to nine positive serologies.
Vascular outcome end-points have also been found to be associated with IB measures. A second study by Zhu et al. in a cohort of 890 subjects with angiographically confirmed CAD who were followed for three years found an association between MI and IB. 51 At least six positive infectious serologies compared with nought to one positive serologies was significantly associated with MI (adjusted RR 3.18, 95% However, not all studies have found an association between IB measures and cardiovascular risk. 55 In an analysis of 1,056 subjects selected from the Multi-Ethnic Study of Atherosclerosis (MESA) cohort, there was no association between IB and IMT or coronary artery calcification. 56 However, there are several limitations to the existing studies. The assessment of IB across these studies fails to distinguish the effects of different pathogens and assumes an equal contribution to disease.
Also, the threshold for determination of a positive serology differs among studies and in some cases was established post hoc.
Furthermore, the prevalence of risk factors and infectious pathogens varies across study samples.
To address some of these concerns of heterogeneity of the IB measurement construct and other potential limitations, NOMAS constructed a novel measure of IB that allows for variable impacts of different pathogens by applying weights for the magnitude of association with stroke, specific to the population under study. 57 The NOMAS cohort is an urban, population-based prospective study in a tri-ethnic population. The IB index comprised weights derived from 
Acute Infection as a Precipitant to Ischemic Stroke
Acute infections may play a specific role in triggering acute vascular events. Thrombotic complications arise when the site of an atherosclerotic plaque becomes destabilized and exposes the underlying pro-coagulant surface. 59 Although macrophage activity has been shown to play a role in fibrous plaque destabilization, 60 
Conclusion
Promising research investigating the role of acute and chronic infectious exposure suggests that there may be a causal role of pathogens in atherosclerotic progression and plaque destabilization to negatively affect vascular risk; however, the evidence is preliminary.
Further studies are required to identify molecular targets for He holds a master's degree in epidemiology from Columbia University.
